Emma Reeve

Emma Reeve has an estimated net worth of $7.02 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Editas Medicine, Inc., Whitehawk Therapeutics, Inc., PTC THERAPEUTICS, INC., and PAREXEL INTERNATIONAL CORP.

2020 was Emma Reeve's most active year for acquiring shares with 24 total transactions. Emma Reeve's most active month to acquire stocks was the month of December. 2020 was Emma Reeve's most active year for disposing of shares, totalling 38 transactions. Emma Reeve's most active month to dispose stocks was the month of April. 2025 saw Emma Reeve paying a total of $2,542,573.69 for 119,271 shares, this is the most they've acquired in one year. In 2025 Emma Reeve cashed out on 141,464 shares for a total of $5,108,195.20, their largest year based on trade value.